Dr. Catherine S. Diefenbach
Claim this profileLaura and Isaac Perlmutter Cancer Center at NYU Langone
Studies Cancer
Studies Non-Hodgkin's Lymphoma
12 reported clinical trials
26 drugs studied
Area of expertise
1Cancer
Stage IV
CCND1 positive
t(11;14) positive
2Non-Hodgkin's Lymphoma
Stage IV
Stage III
CCND1 positive
Affiliated Hospitals
Clinical Trials Catherine S. Diefenbach is currently running
CC-99282 + Anti-Lymphoma Agents
for Non-Hodgkin's Lymphoma
This trial is testing a new drug, CC-99282, for patients with certain types of lymphoma who haven't responded to other treatments. Researchers are finding the safest dose and checking if it works better alone or with other drugs.
Recruiting1 award Phase 1 & 22 criteria
PRO1160
for Advanced Cancer
This trial tests PRO1160, a targeted cancer treatment, in patients with advanced or hard-to-remove cancers. PRO1160 uses an antibody to find cancer cells and a drug to kill them.
Recruiting1 award Phase 1 & 25 criteria
More about Catherine S. Diefenbach
Clinical Trial Related6 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Catherine S. Diefenbach has experience with
- Rituximab
- Nivolumab
- Decitabine And Cedazuridine
- Tafasitamab
- CC-99282
- Obinutuzumab
Breakdown of trials Catherine S. Diefenbach has run
Cancer
Non-Hodgkin's Lymphoma
B-Cell Lymphoma
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Catherine S. Diefenbach specialize in?
Catherine S. Diefenbach focuses on Cancer and Non-Hodgkin's Lymphoma. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are CCND1 positive.
Is Catherine S. Diefenbach currently recruiting for clinical trials?
Yes, Catherine S. Diefenbach is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Catherine S. Diefenbach has studied deeply?
Yes, Catherine S. Diefenbach has studied treatments such as Rituximab, Nivolumab, Decitabine and Cedazuridine.
What is the best way to schedule an appointment with Catherine S. Diefenbach?
Apply for one of the trials that Catherine S. Diefenbach is conducting.
What is the office address of Catherine S. Diefenbach?
The office of Catherine S. Diefenbach is located at: Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York 10016 United States. This is the address for their practice at the Laura and Isaac Perlmutter Cancer Center at NYU Langone.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.